Subscribe Us

header ads

Recents

header ads

Medical Devices Market Size, Growth, Demands Outlook and Forecasts to 2030

Precedence Research - December 23, 2022

 According to the research report, the global medicaldevices market size is expected to touch USD 850 Billion by 2030, from USD 550 Billion in 2021, growing with a significant CAGR of 5.5% from 2022 to 2030. 

Medical Devices Market Size 2021 to 2030

The medical devices market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global medical devices market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global medical devices market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global medical devices market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1129

 Report Scope of the Medical Devices Market

Report HighlightsDetails
Market SizeUSD 850 Billion by 2030
Growth RateCAGR of 5.5% From 2022 to 2030
Largest MarketNorth America
Base Year2021
Forecast Period2022 to 2027
Segments CoveredProduct, Therapeutic Application, End User, Region
Regional ScopeAsia Pacific, North America, Europe, Latin America, Middle East and Africa

This study covers a detailed segmentation of the global medical devices market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global medical devices market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • DePuy Synthes
  • Medtronics Plc
  • Fesenius Medical Care
  • GE Healthcare
  • Philips Healthcare
  • Ethicon LLC
  • Siemens Healthineers
  • Stryker
  • Cardinal Health
  • Baxter International Inc.
  • BD

Market Segmentation

 By Product

  • Monitoring Devices
  • Cardiac Monitoring Devices
  • Neuromonitoring Devices
  • Respiratory Monitoring Device
  • Multi-Parameter Monitoring Devices
  • Hemodynamic Monitoring Devices
  • Fetal and Neonatal Monitoring Devices
  • Temperature Monitoring Devices
  • Weight Monitoring Devices
  • Diagnostic Devices
  • Surgical ENT Devices.
  • Endoscopes
  • Imaging Devices
  • Diagnostic Molecular Devices
  • Drug Delivery Devices
  • Surgical Devices
  • Bio Implants and Stimulation Devices
  • Treatment Equipment
  • Infusion Pumps
  • Medical lasers and LASIK surgical machines
  • Others

By Therapeutic Application

  • Gastrointestinal surgery
  • General Surgery
  • Diagnostic Imaging
  • Respiratory
  • Orthopedics
  • Cardiovascular
  • Dental
  • Neurology
  • Ophthalmology
  • Ear-Nose-Throat (ENT)
  • Nephrology and Urology
  • Others

By End User

  • Hospitals & Clinics
  • Diagnostic Centers
  • Research laboratory
  • Pharmaceutical companies

By Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Rest of the World

Research Methodology

The research methodology adopted by analysts for compiling the global medical devices market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global medical devices market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Devices Market 

5.1. COVID-19 Landscape: Medical Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Devices Market, By Product

8.1. Medical Devices Market, by Product Type, 2022-2030

8.1.1. Monitoring Devices

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Cardiac Monitoring Devices

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Respiratory Monitoring Device

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Multi-Parameter Monitoring Devices

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Hemodynamic Monitoring Devices

8.1.5.1. Market Revenue and Forecast (2019-2030)

8.1.6. Fetal and Neonatal Monitoring Devices

8.1.6.1. Market Revenue and Forecast (2019-2030)

8.1.7. Temperature Monitoring Devices

8.1.7.1. Market Revenue and Forecast (2019-2030)

8.1.8. Weight Monitoring Devices

8.1.8.1. Market Revenue and Forecast (2019-2030)

8.1.9. Diagnostic Devices

8.1.9.1. Market Revenue and Forecast (2019-2030)

8.1.10. Surgical ENT Devices.

8.1.10.1. Market Revenue and Forecast (2019-2030)

8.1.11. Endoscopes

8.1.11.1. Market Revenue and Forecast (2019-2030)

8.1.12. Imaging Devices

8.1.12.1. Market Revenue and Forecast (2019-2030)

8.1.13. Diagnostic Molecular Devices

8.1.13.1. Market Revenue and Forecast (2019-2030)

8.1.14. Drug Delivery Devices

8.1.14.1. Market Revenue and Forecast (2019-2030)

8.1.15. Surgical Devices

8.1.15.1. Market Revenue and Forecast (2019-2030)

8.1.16. Bio Implants and Stimulation Devices

8.1.16.1. Market Revenue and Forecast (2019-2030)

8.1.17. Treatment Equipment

8.1.17.1. Market Revenue and Forecast (2019-2030)

8.1.18. Infusion Pumps

8.1.18.1. Market Revenue and Forecast (2019-2030)

8.1.19. Medical lasers and LASIK surgical machines

8.1.19.1. Market Revenue and Forecast (2019-2030)

8.1.20. Others

8.1.20.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Medical Devices Market, By Therapeutic Application

9.1. Medical Devices Market, by Therapeutic Application, 2022-2030

9.1.1. Gastrointestinal surgery

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. General Surgery

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Diagnostic Imaging

9.1.3.1. Market Revenue and Forecast (2019-2030)

9.1.4. Respiratory

9.1.4.1. Market Revenue and Forecast (2019-2030)

9.1.5. Orthopedics

9.1.5.1. Market Revenue and Forecast (2019-2030)

9.1.6. Cardiovascular

9.1.6.1. Market Revenue and Forecast (2019-2030)

9.1.7. Dental

9.1.7.1. Market Revenue and Forecast (2019-2030)

9.1.8. Neurology

9.1.8.1. Market Revenue and Forecast (2019-2030)

9.1.9. Ophthalmology

9.1.9.1. Market Revenue and Forecast (2019-2030)

9.1.10. Ear-Nose-Throat (ENT)

9.1.10.1. Market Revenue and Forecast (2019-2030)

9.1.11. Nephrology and Urology

9.1.11.1. Market Revenue and Forecast (2019-2030)

9.1.12. Others

9.1.12.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Medical Devices Market, By End User 

10.1. Medical Devices Market, by End User, 2022-2030

10.1.1. Hospitals & Clinics

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Diagnostic Centers

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Research laboratory

10.1.3.1. Market Revenue and Forecast (2019-2030)

10.1.4. Pharmaceutical Companies

10.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Medical Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.1.3. Market Revenue and Forecast, by End User (2019-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.2.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.6.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.7.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.3.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.6.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.7.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.6.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.7.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.4.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.5.2. Market Revenue and Forecast, by Therapeutic Application (2019-2030)

11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)

Chapter 12. Company Profiles

12.1. Medtronics Plc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Johnson & Johnson

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Fesenius Medical Care

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. DePuy Synthes

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Abbott Laboratories

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. GE Healthcare

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Philips Healthcare

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Ethicon LLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Siemens Healthineers AG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Stryker

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

12.11. Cardinal Health

12.11.1. Company Overview

12.11.2. Product Offerings

12.11.3. Financial Performance

12.11.4. Recent Initiatives

12.12. Baxter International Inc.

12.12.1. Company Overview

12.12.2. Product Offerings

12.12.3. Financial Performance

12.12.4. Recent Initiatives

12.13. BD

12.13.1. Company Overview

12.13.2. Product Offerings

12.13.3. Financial Performance

12.13.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments